Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
enabled [disable] Abstract
Number of results

Results found: 4

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  anosmia
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
Objectives: To determine the incidence of smell and taste disorders in our health department and to analyse the factors that could be associated with these symptoms in patients with COVID-19. Methods: We conducted an observational descriptive study of all patients with COVID-19 in our health area diagnosed between 2020/03/10 and 2020/04/14. Factors related to smell and taste disorders were analysed. Results: A total of 126 patients, 63 women and 63 men, aged 16–80 years, were included. As many as 69 patients (62.7%) presented hyposmia, and 58 (46%) of them had anosmia. A total of 75 patients (59.5%) presented hypogeusia, and 57 (45.2%) of them had ageusia. The risk factors that were most commonly associated with these disorders were the female sex (adjusted odds ratio, aOR 2.43 for smell disorders and 2.44 for taste disorders), allergic rhinitis (aOR 3.34 for smell disorders) and a younger age. A protective factor was arterial hypertension (aOR 0.51 for smell disorders and 0.35 for taste disorders). A history of tonsillectomy was the risk factor for taste disorder (aOR 5.23). Conclusion: Our results indicate that these sensory disorders occurred more frequently in female patients and in young patients with mild to moderate COVID-19 infection who progressed with mild nasal congestion, posterior rhinorrhoea and without anterior rhinorrhoea. The recovery of taste occurred before the recovery of smell.
2
86%
PL
Pandemia COVID-19 jest wynikiem postępującej globalizacji. Jednak właśnie dzięki wysiłkom klinicystów i umiędzynarodowieniu współpracy ośrodków badawczych nieustannie opracowywane są najlepsze metody diagnostyki oraz leczenia zakażenia COVID-19. Zgodnie z najaktualniejszymi badaniami, do najwcześniej występujących objawów zostały zaliczone zaburzenia węchu. Niniejsza praca poglądowa stanowi syntetyczny zbiór i podsumowanie aktualnego piśmiennictwa na temat występowania zaburzeń węchu u chorych na SARS-Cov-19. W artykule prezentowane są: mechanizmy patofizjologiczne, typowy obraz kliniczny oraz dostępne narzędzia diagnostyczne dla prawidłowego rozpoznawania zaburzeń węchu u chorych na SARS-Cov-19. W dyskusji wyróżniona została skuteczność olfaktometrii psychofizycznej i dokładnego wywiadu lekarskiego. Autorzy pracy sugerują możliwość skutecznego prowadzenia diagnostyki zaburzeń węchu w formie telekonsultacji oraz podkreślają, jak istotna jest rola laryngologów w diagnostyce COVID-19 i konieczność rozpowszechniania wiedzy na temat zaburzeń węchu w kontekście ograniczenia pandemii. Postulują również utworzenie prostego modelu opartego o badanie przedmiotowe i podmiotowe, który z wysoką czułością rozpoznawałby zakażenia SARS-CoV-2. Docenienie wagi zaburzeń węchu może pozwolić na skuteczniejsze izolowanie bezobjawowych nosicieli, co wyraźnie zahamowałoby rozwój pandemii. Ponadto w pracy zaprezentowane zostało postępowanie terapeutyczne w przypadku zaburzeń węchu utrzymujących się dłużej niż dwa tygodnie.
3
86%
EN
The COVID-19 pandemic is a result of increasing globalization. However, thanks to clinicians’ efforts and the cooperation between research centers, the best methods for diagnosis and treatment of COVID-19 infection are constantly being developed. According to the most recent research, olfactory disorders have been included in the earliest symptoms. This article is a synthetic summary of current literature about the occurrence of olfactory disorders in patients with SARS-Cov-19. The article presents pathophysiological mechanisms, a typical clinical image and the available diagnostic tools for a better understanding of olfactory disorders in patients with SARS-Cov-19. The effectiveness of psychophysical olfactometry and accurate medical history was highlighted in the discussion. The authors suggest the possibility of effective diagnostics of olfactory disorders in the form of teleconsultation and emphasize the importance of the role of laryngologists in the diagnosis of COVID-19 and the need to disseminate knowledge about olfactory disorders to inhibit the SARS-CoV-19 pandemic. The authors postulate to create a simple model based on physical examination, which would recognize SARS-Cov-19 infection with high sensitivity. Appreciating the importance of olfactory disorders may allow for more effective isolation of asymptomatic carriers, which would clearly inhibit the development of COVID-19 pandemic. In addition, the paper presents therapeutic management of olfactory dysfunction lasting for more than two weeks.
EN
Since the first confirmed case in Wuhan, China on December 31, 2019, the novel coronavirus (SARS-CoV-2) has spread quickly, infecting 165 million people as of May 2021. Since this first detection, research has indicated that people contracting the virus may suffer neurological and mental disorders and deficits, in addition to the respiratory and other organ challenges caused by COVID-19. Specifically, early evidence suggests that COVID-19 has both mild (e.g., loss of smell (anosmia), loss of taste (ageusia), latent blinks (heterophila), headaches, dizziness, confusion) and more severe outcomes (e.g., cognitive impairments, seizures, delirium, psychosis, strokes). Longer-term neurological challenges or damage may also occur. This knowledge should inform clinical guidelines, assessment, and public health planning while more systematic research using biological, clinical, and longitudinal methods provides further insights.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.